Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 498
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Suowen Xu, Iqra Ilyas, Jianping Weng
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 695-709
Open Access | Times Cited: 270
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 178
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection
Julian Heuberger, Jakob Trimpert, Daria Vladimirova, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 74
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease
Manish Purohit, Gaurav Gupta, Obaid Afzal, et al.
Chemico-Biological Interactions (2023) Vol. 371, pp. 110334-110334
Closed Access | Times Cited: 29
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 8
The infection risks of JAK inhibition
Maryam Adas, Edward Alveyn, Emma Cook, et al.
Expert Review of Clinical Immunology (2021) Vol. 18, Iss. 3, pp. 253-261
Open Access | Times Cited: 53
Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects
Sabina Semiz
Journal of Trace Elements in Medicine and Biology (2021) Vol. 69, pp. 126887-126887
Open Access | Times Cited: 43
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107586-107586
Open Access | Times Cited: 42
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
Roman Maslennikov, В. Т. Ивашкин, Ekaterina Vasilieva, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 69, pp. 102039-102039
Open Access | Times Cited: 41
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Jiajing Zheng, Jiameng Miao, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid‐19 pathology
Bahjat Al‐Ani, Asmaa Mohammed ShamsEldeen, Samaa Samir Kamar, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 4, pp. 483-491
Closed Access | Times Cited: 29
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19
Qiaoyun Gong, Mingshui Fu, Jingyi Wang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 7, pp. 2587-2597
Open Access | Times Cited: 6
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches
Ali Attiq, Sheryar Afzal, Habibah A. Wahab, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4215-4240
Open Access | Times Cited: 6
Unravelling the Potential of Anticancer Drugs for SARS-CoV-2
Zheng Yao Low, Ka Heng Wong, Ashley Jia Wen Yip, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Open Access
Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection
Dayeon Lee, Sin Young Choi, S Shin, et al.
(2025)
Open Access
Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection
Dayeon Lee, Sin Young Choi, S Shin, et al.
(2025)
Open Access
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
Min-Tser Liao, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1440-1440
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top